ArticleThe lancet. Diabetes & endocrinology2013
Restoring immune balance in type 1 diabetes.
Article in The lancet. Diabetes & endocrinology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00965458 (Inducing Remission in New Onset Type 1 Diabetes Mellitus With Alefacept), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Inducing Remission in New Onset Type 1 Diabetes Mellitus With Alefacept (Amevive®)
Who cites it
3 citing papers in PubMed.
- Conversion of Gastrointestinal Somatostatin-Expressing D Cells Into Insulin-Producing Beta-Like Cells UponFrontiers in endocrinology · 2022Article
- Decreased expression of programmed death-1 on CD8Acta diabetologica · 2021Article
- Pancreatic nerve electrostimulation inhibits recent-onset autoimmune diabetes.Nature biotechnology · 2019Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
24622404What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.